Preview of a proof-of-concept study examining a single-dose cognitive ingredient's acute effects on brain activity and performance, relevant for formulators.
Key Takeaways
- Randomized double-blind placebo-controlled crossover tested a single 500 mg dose versus placebo
- Outcomes included EEG brain-wave analysis, validated cognitive tasks, and mood assessments
- Participants were assessed at 60 and 240 minutes post-ingestion to gauge onset and duration